MSH6 and cancer: Pathogenic variants in MSH6 have been associated with cancers other than colorectal carcinomas, including endometrial (Hendriks et al. 2004) and nonmelanoma skin cancers (Barrow et al. 2009); however, melanomas have yet to be confirmed in the tumour predisposition spectrum (Liu et al. 2022).